Cross-source evidence timeline

Eptifibatide research timeline

Follow 65 selected, directly cited source records from December 17, 1997 through November 3, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

65Selected records
19Source years
3Evidence lanes
November 3, 2026Latest source date

Source year

2026

5 records
  1. Literature metadata

    Thrombolysis Alone vs With Argatroban or Eptifibatide: A Prespecified Subgroup Analysis of the MOST Trial.↗

    PubMed lists PMID 41071964 in Neurology as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III, Multicenter Study, Comparative Study, with publication-date metadata of 2025-10-10 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Evaluation of the Rational use of Eptifibatide among Patients with Acute Coronary Syndrome Referred to Shahid Chamran Heart Hospital.↗

    PubMed lists PMID 42846822 in Journal of research in pharmacy practice as Journal Article, with publication-date metadata of 2026-02-24 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial.↗

    PubMed lists PMID 18772447 in Stroke as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, with publication-date metadata of 2008-09-04 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic stroke.↗

    PubMed lists PMID 24534128 in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2014-02-15 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    Eptifibatide in post-infarction angina patients who refused intervention: Ajmer postmyocardial infarction angina eptifibatide research (AJMER) study: a pilot study.↗

    PubMed lists PMID 25892271 in Cardiovascular therapeutics as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2015-08 (month precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2025

3 records
  1. Literature metadata

    Prophylactic Intra-Arterial Eptifibatide in Stent-Assisted Coiling and Flow Diverter Treatment of Cerebral Aneurysms: A Single-Center Retrospective Analysis.↗

    PubMed lists PMID 41227129 in Journal of clinical medicine as Journal Article, with publication-date metadata of 2025-10-31 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Unraveling the role of the homoarginine residue in antiplatelet drug eptifibatide in binding to the αIIbβ3 integrin receptor.↗

    PubMed lists PMID 35926348 in Thrombosis research as Journal Article, with publication-date metadata of 2022-07-25 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT03735979↗

    PeptideScanner retained ClinicalTrials.gov record NCT03735979 at 2026-11-15T21:59:29.646Z. Its registry update date was 2025-02-07, and PeptideScanner's reviewed identity mapping was eptifibatide.↗

Source year

2024

4 records
  1. Literature metadata

    Eptifibatide use in ischemic stroke patients undergoing endovascular thrombectomy: A matched cohort analysis.↗

    PubMed lists PMID 36237613 in Frontiers in neurology as Journal Article, with publication-date metadata of 2022-09-27 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease.↗

    PubMed lists PMID 23973010 in Thrombosis research as Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, with publication-date metadata of 2013-08-08 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT00089895↗

    PeptideScanner retained ClinicalTrials.gov record NCT00089895 at 2026-11-15T21:59:29.646Z. Its registry update date was 2024-05-17, and PeptideScanner's reviewed identity mapping was eptifibatide.↗

  4. Regulatory

    Drugs@FDA application ANDA213599↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 213599 with status AP dated 2024-05-09, and names eptifibatide among the application record's active ingredients.↗

Source year

2023

1 record
  1. Literature metadata

    Eptifibatide, an Older Therapeutic Peptide with New Indications: From Clinical Pharmacology to Everyday Clinical Practice.↗

    PubMed lists PMID 36982519 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2023-03-13 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2022

3 records
  1. Regulatory

    Federal Register notice 2022-17056↗

    The Federal Register published notice 2022-17056, attributed to FDA and its parent HHS department, on 2022-08-09. Its official title is “Determination That AVC (Sulfanilamide) Vaginal Cream, 15%, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Eptifibatide.↗

  2. Literature metadata

    Acute intraprocedural thrombosis during an arterial ductal stenting successfully managed by eptifibatide.↗

    PubMed lists PMID 34462026 in Cardiology in the young as Journal Article, with publication-date metadata of 2021-08-31 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Optimization of RGD-modified Nano-liposomes Encapsulating Eptifibatide.↗

    PubMed lists PMID 28959324 in Iranian journal of biotechnology as Journal Article, with publication-date metadata of 2016-06 (month precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2021

6 records
  1. Regulatory

    Federal Register notice 2021-25111↗

    The Federal Register published notice 2021-25111, attributed to FDA and its parent HHS department, on 2021-11-18. Its official title is “Discovery Therapeutics, LLC, et al.; Withdrawal of Approval of 18 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin and Eptifibatide.↗

  2. Literature metadata

    The kinetics of integrilin limited by obesity: a multicenter randomized pharmacokinetic and pharmacodynamic clinical trial.↗

    PubMed lists PMID 22137072 in American heart journal as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2011-11-08 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Regulatory

    Drugs@FDA application ANDA213081↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 213081 with status AP dated 2021-09-07, and names eptifibatide among the application record's active ingredients.↗

  4. Regulatory

    Federal Register notice 2021-16047↗

    The Federal Register published notice 2021-16047, attributed to FDA and its parent HHS department, on 2021-07-28. Its official title is “Fresenius Kabi USA, LLC, et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Eptifibatide.↗

  5. Clinical trials

    ClinicalTrials.gov record NCT01522417↗

    PeptideScanner retained ClinicalTrials.gov record NCT01522417 at 2026-11-15T21:59:29.646Z. Its registry update date was 2021-05-13, and PeptideScanner's reviewed identity mapping was eptifibatide.↗

  6. Literature metadata

    Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.↗

    PubMed lists PMID 25523054 in Stroke as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, with publication-date metadata of 2014-12-18 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2020

5 records
  1. Literature metadata

    The Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices.↗

    PubMed lists PMID 28621461 in Artificial organs as Journal Article, with publication-date metadata of 2017-06-16 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Eptifibatide use following emergent carotid stenting in acute anterior circulation ischemic stroke with tandem occlusion.↗

    PubMed lists PMID 32807436 in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association as Journal Article, with publication-date metadata of 2020-06-17 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Tibial bypass salvage with eptifibatide in a patient with thrombocythemia.↗

    PubMed lists PMID 31724642 in Journal of vascular surgery cases as Case Reports, Journal Article, with publication-date metadata of 2015-11-01 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT02925923↗

    PeptideScanner retained ClinicalTrials.gov record NCT02925923 at 2026-11-15T21:59:29.646Z. Its registry update date was 2020-05-04, and PeptideScanner's reviewed identity mapping was eptifibatide.↗

  5. Regulatory

    Drugs@FDA application ANDA207864↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 207864 with status AP dated 2020-03-20, and names eptifibatide among the application record's active ingredients.↗

Source year

2019

6 records
  1. Literature metadata

    Pharmacokinetic and pharmacodynamic properties of eptifibatide in subjects with normal or impaired renal function.↗

    PubMed lists PMID 15110131 in Clinical therapeutics as Clinical Trial, Journal Article, Multicenter Study, with publication-date metadata of 2004-03 (month precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    αIIbβ3-integrin Ligands: Abciximab and Eptifibatide as Proapoptotic Factors in MCF-7 Human Breast Cancer Cells.↗

    PubMed lists PMID 25090985 in Current drug targets as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015 (year precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Validated High Performance Liquid Chromatographic Method for Stability Study of Eptifibatide.↗

    PubMed lists PMID 31004428 in Journal of chromatographic science as Journal Article, with publication-date metadata of 2019-07-01 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Regulatory

    Drugs@FDA application ANDA204361↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 204361 with status AP dated 2019-03-14, and names eptifibatide among the application record's active ingredients.↗

  5. Regulatory

    Drugs@FDA application ANDA204362↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 204362 with status AP dated 2019-03-11, and names eptifibatide among the application record's active ingredients.↗

  6. Regulatory

    Drugs@FDA application ANDA209864↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 209864 with status AP dated 2019-01-25, and names eptifibatide among the application record's active ingredients.↗

Source year

2018

14 records
  1. Literature metadata

    Prolonged use of eptifibatide as a bridge to maintain drug-eluting stent patency in a patient receiving extracorporeal membrane oxygenation.↗

    PubMed lists PMID 29874954 in Perfusion as Case Reports, Journal Article, with publication-date metadata of 2018-06-06 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Comparison of ecchymosis rates with measurement of automated and manual blood pressures in patients receiving eptifibatide therapy.↗

    PubMed lists PMID 21127429 in The Journal of cardiovascular nursing as Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2011 Jan-Feb (source-text precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Eptifibatide in coronary intervention: past time for the next chapter.↗

    PubMed lists PMID 25657317 in Circulation. Cardiovascular interventions as Editorial, Comment, with publication-date metadata of 2015-02 (month precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Using Zero-Balance Ultrafiltration With Dialysate as a Replacement Solution for Toxin and Eptifibatide Removal on a Dialysis-Dependent Patient During Cardiopulmonary Bypass.↗

    PubMed lists PMID 25857672 in Journal of cardiothoracic and vascular anesthesia as Case Reports, Journal Article, with publication-date metadata of 2014-12-08 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    [EXPERIENCE WITH THE USE OF EPTIFIBATIDE IN ACUTE CORONARY SYNDROME DURING CORONARY INTERVENTION IN PATIENTS OLDER AGE GROUP].↗

    PubMed lists PMID 28423263 in Advances in gerontology = Uspekhi gerontologii as Journal Article, with publication-date metadata of 2016 (year precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Literature metadata

    Present and evolving role of eptifibatide in the treatment of acute coronary syndromes.↗

    PubMed lists PMID 17489665 in Expert review of cardiovascular therapy as Journal Article, Review, with publication-date metadata of 2007-05 (month precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  7. Literature metadata

    Phase I study of eptifibatide in patients with sickle cell anaemia.↗

    PubMed lists PMID 17916103 in British journal of haematology as Clinical Trial, Phase I, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-10-03 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  8. Literature metadata

    A review of clinical trials with eptifibatide in cardiology.↗

    PubMed lists PMID 18078431 in Cardiovascular drug reviews as Journal Article, Review, with publication-date metadata of 2007 Winter (source-text precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  9. Literature metadata

    Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: the INtegrilin plus STenting to Avoid myocardial Necrosis Trial.↗

    PubMed lists PMID 22607870 in American heart journal as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2012-05 (month precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  10. Literature metadata

    [Value of eptifibatide during salvage angioplasty with coronary stenting after failure of thrombolysis. Report of a series of 41 patients].↗

    PubMed lists PMID 12462900 in Archives des maladies du coeur et des vaisseaux as Clinical Trial, Journal Article, with publication-date metadata of 2002-10 (month precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  11. Regulatory

    Drugs@FDA application ANDA208554↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 208554 with status AP dated 2018-11-23, and names eptifibatide among the application record's active ingredients.↗

  12. Regulatory

    Drugs@FDA application ANDA203258↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 203258 with status AP dated 2018-07-20, and names eptifibatide among the application record's active ingredients.↗

  13. Regulatory

    Drugs@FDA application ANDA204693↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 204693 with status AP dated 2018-03-07, and names eptifibatide among the application record's active ingredients.↗

  14. Clinical trials

    ClinicalTrials.gov record NCT01103440↗

    PeptideScanner retained ClinicalTrials.gov record NCT01103440 at 2026-11-15T21:59:29.646Z. Its registry update date was 2018-02-14, and PeptideScanner's reviewed identity mapping was eptifibatide.↗

Source year

2017

3 records
  1. Regulatory

    Drugs@FDA application ANDA205557↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 205557 with status AP dated 2017-11-06, and names eptifibatide among the application record's active ingredients.↗

  2. Regulatory

    Drugs@FDA application ANDA204589↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 204589 with status AP dated 2017-04-18, and names eptifibatide among the application record's active ingredients.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT01919723↗

    PeptideScanner retained ClinicalTrials.gov record NCT01919723 at 2026-11-15T21:59:29.646Z. Its registry update date was 2017-02-28, and PeptideScanner's reviewed identity mapping was eptifibatide.↗

Source year

2016

2 records
  1. Clinical trials

    ClinicalTrials.gov record NCT01076764↗

    PeptideScanner retained ClinicalTrials.gov record NCT01076764 at 2026-11-15T21:59:29.646Z. Its registry update date was 2016-05-04, and PeptideScanner's reviewed identity mapping was eptifibatide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT01977456↗

    PeptideScanner retained ClinicalTrials.gov record NCT01977456 at 2026-11-15T21:59:29.646Z. Its registry update date was 2016-01-21, and PeptideScanner's reviewed identity mapping was eptifibatide.↗

Source year

2015

3 records
  1. Regulatory

    Drugs@FDA application ANDA206127↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 206127 with status AP dated 2015-12-08, and names eptifibatide among the application record's active ingredients.↗

  2. Regulatory

    Drugs@FDA application ANDA090854↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 090854 with status AP dated 2015-06-12, and names eptifibatide among the application record's active ingredients.↗

  3. Regulatory

    Drugs@FDA application ANDA091555↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 091555 with status AP dated 2015-06-05, and names eptifibatide among the application record's active ingredients.↗

Source year

2014

2 records
  1. Clinical trials

    ClinicalTrials.gov record NCT00317395↗

    PeptideScanner retained ClinicalTrials.gov record NCT00317395 at 2026-11-15T21:59:29.646Z. Its registry update date was 2014-12-03, and PeptideScanner's reviewed identity mapping was eptifibatide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT00894803↗

    PeptideScanner retained ClinicalTrials.gov record NCT00894803 at 2026-11-15T21:59:29.646Z. Its registry update date was 2014-04-17, and PeptideScanner's reviewed identity mapping was eptifibatide.↗

Source year

2013

3 records
  1. Clinical trials

    ClinicalTrials.gov record NCT00111566↗

    PeptideScanner retained ClinicalTrials.gov record NCT00111566 at 2026-11-15T21:59:29.646Z. Its registry update date was 2013-11-28, and PeptideScanner's reviewed identity mapping was eptifibatide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT01863134↗

    PeptideScanner retained ClinicalTrials.gov record NCT01863134 at 2026-11-15T21:59:29.646Z. Its registry update date was 2013-10-31, and PeptideScanner's reviewed identity mapping was eptifibatide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT00061373↗

    PeptideScanner retained ClinicalTrials.gov record NCT00061373 at 2026-11-15T21:59:29.646Z. Its registry update date was 2013-02-04, and PeptideScanner's reviewed identity mapping was eptifibatide.↗

Source year

2012

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT00426751↗

    PeptideScanner retained ClinicalTrials.gov record NCT00426751 at 2026-11-15T21:59:29.646Z. Its registry update date was 2012-11-27, and PeptideScanner's reviewed identity mapping was eptifibatide.↗

Source year

2010

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT00638976↗

    PeptideScanner retained ClinicalTrials.gov record NCT00638976 at 2026-11-15T21:59:29.646Z. Its registry update date was 2010-05-28, and PeptideScanner's reviewed identity mapping was eptifibatide.↗

Source year

2009

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT00250991↗

    PeptideScanner retained ClinicalTrials.gov record NCT00250991 at 2026-11-15T21:59:29.646Z. Its registry update date was 2009-05-08, and PeptideScanner's reviewed identity mapping was eptifibatide.↗

Source year

1998

1 record
  1. Regulatory

    Drugs@FDA application NDA020718↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 020718 with status AP dated 1998-05-18, and names eptifibatide among the application record's active ingredients.↗

Source year

1997

1 record
  1. Regulatory

    Federal Register notice 97-32874↗

    The Federal Register published notice 97-32874, attributed to FDA and its parent HHS department, on 1997-12-17. Its official title is “Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Eptifibatide.↗